TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Aesthetic outcome by Copenhagen Index Scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in quality of life summary scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in Tumor Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Maximum (peak) observed blood and urine drug concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach maximum (peak) blood and urine drug concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Two-point pain improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal Functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Expression status of biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood flow in lower leg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interference with Sentinel Lymph Node mapping procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of the imaging system for the surgeon
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaction time and accuracies of responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensory block onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor block onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability/Safety
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetics of fluvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Patient Rated Tennis Elbow Evaluation (PRTEE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Protective effect on mucous membranes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in size of Left Atrial Epicardial Adipose Tissue (LAEAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in peri-implant pocket probing depth (PPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in moderate or vigorous physical activity (MVPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Low-Density Lipoprotein cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time from discontinuing anesthesia to extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Accuracy of Dual Energy CT for Detecting Varices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Difference in Length of Hospital Stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Concordance of mobility measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days to platelet count rebound to 75×10^9/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Days to platelet count rebound to 100×10^9/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in microflora
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in loudness growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in temporal resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in spectral resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of Revision/Removal/Unanticipated Adverse Device Effect (UADE)
Endpoint domain: Adverse events/effects
Primary endpoint: The Knee Society Assessment Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Inflammatory Bowel Disease Symptom Severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sufficiency of pain medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Olfactory Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Precision of lesioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Lesion characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to normal coagulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Physiological testing results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Youth Self-Report (YSR)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-Report of Delinquent Behavior Scale
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: Proportion of surviving patients without need for intubation
Endpoint domain: Mortality/survival
Primary endpoint: Total Examination Time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Kappa-measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve From Time Zero to Last Quantifiable Concentration (AUC [0-t])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cormack Lehane Laryngeal view
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: POGP score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average DAS28-CRP over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BDI
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SCL-90 Dyadic Adjustment Scale (DAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline neuropsychological performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postural sways
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset of lactogenesis II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Milk production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-day Smoking Abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of inpatient post-operative delirium
Endpoint domain: Adverse events/effects
Primary endpoint: K-MMSE (Korean Mini-Mental Status Examination)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in microvolt T wave alternans status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in CSF Total-tau From Baseline to End of Study (pg/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in p-tau181 From Baseline to End of Study (pg/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Amyloid Beta 42 From Baseline to End of Study (pg/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pathological complete response rate (pCR)
Endpoint domain: Mortality/survival
Primary endpoint: Spine Bone Mineral Density (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Carboplatin Pharmacokinetics: Area Under the Concentration Versus Time Curve (AUC[0-∞])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cetuximab Pharmacokinetics: Area Under the Concentration Versus Time Curve During One Dosing Interval at Steady State (AUC τ,ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Carboplatin Pharmacokinetics: Maximum Observed Plasma Concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive Failure Questionnaire (CFQ)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Behavior Rating Inventory of Executive Function Adult version (BRIEF-A)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Investigator-Confirmed Angioedema Attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: incidence of MDD relapse/recurrence
Endpoint domain: Mortality/survival
Primary endpoint: time to MDD relapse/recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants Who Developed Grade 3 or Higher Pneumonitis
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of sustained suppression of HBV DNA <2000 IU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Diluent Challenge Contralateral Secretion Weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Carotid-femoral Pulse Wave Velocity (CFPWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of Bowel Cleanliness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of Adverse Events Experienced by Patient
Endpoint domain: Adverse events/effects
Primary endpoint: Skin appearance modification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Completion of the Geriatric Assessment (GA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change From Baseline in Positive and Negative Syndrome Scale-Excited Component (PEC) Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Retinal Nerve Fiber Layer thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Up-take of antibiotic prescription
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in maximal oxygen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urogenital distress inventory (UDI-6)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MYMOP (Measure Yourself Medical Outcome Profile)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: ORIDL (Outcome Related to Impact on Daily Living)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Prostate Specific Antigen (PSA) Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial increment glucose under the area curve (iAUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Long-term weight maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of participants with pelvic sepsis
Endpoint domain: Adverse events/effects
Primary endpoint: Composite of complete or partial remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change From Baseline in Trough Sitting Systolic Blood Pressure (SiSBP) at Week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Change From Baseline in Trough Sitting Diastolic Blood Pressure (SiDBP) at Week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Change From Baseline in Trough Sitting Diastolic Blood Pressure (SiDBP) at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Change From Baseline in Trough Sitting Systolic Blood Pressure (SiSBP) at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical symptoms of allergic rhinitis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of subjects with anti polio titer ≥ 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Presence of dengue virus-specific immunoglobulin G antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Eye Movement Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rey-Osterrieth Complex Figure Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Benton test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Corsi Block Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Annualized Bleed Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Presence of gingival and periodontal disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Risk of developing dental caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Reports of bruxism activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Prevalence of SO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceived dyspnea
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Occurrence of severe RV GE
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of circulating activated neutrophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Event Free Survival (EFS) probability
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients completing the treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to adjuvant systemic chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global improvement in IBS
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Combined Bone Mass Density T-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Body mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of subjects with at least one Treatment-emergent Adverse Event (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of subjects who withdrew due to an Treatment-emergent Adverse Event (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Anti-tetanus seroprotection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Metastasis to regional lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: In-hospital mortality of STEMI patients
Endpoint domain: Mortality/survival
Primary endpoint: Safety of the Influenza vaccine Fluviral 2009/10
Endpoint domain: Adverse events/effects
Primary endpoint: Successful external version
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change in MDS-UPDRS Combined Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve From Time Zero to the Time of the Last Measured Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve From Zero to Infinity (AUC 0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary Function FEC/FVC Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Clinical response to COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunological response to COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Genetic predisposition to COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiome-related response to COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: antiviral efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Primary care interval
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change for baseline of intra-ocular pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of progression-free survivors
Endpoint domain: Mortality/survival
Primary endpoint: Lipid biochemistry changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in ABC Irritability Subscale Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survived to Hospital Discharge
Endpoint domain: Mortality/survival
Primary endpoint: Survived Neurologically-Intact
Endpoint domain: Mortality/survival
Primary endpoint: Percent change in Triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent change in HDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants Who Develop Liver Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Gastrointestinal Symptom Rating Scale (GSCG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of moderate and severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Safety as assessed by local and systemic reactogenicity signs and symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Safety as assessed by laboratory measures
Endpoint domain: Adverse events/effects
Primary endpoint: Safety as assessed by adverse and serious experiences
Endpoint domain: Adverse events/effects
Primary endpoint: Vaccine response to tetanus vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: change in severity of pain at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in function (percentage of disability)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pain levels on propofol injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric Quality of life Inventory Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maximal uterine tone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Reduction of risk factors for drug use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with HbA1c <7%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Daily insulin requirement <0.50 IU/Kg/day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent Change in Objective Sleep Efficiency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Foot pressure measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specific joint score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Antibody positive conversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Severity of pelvic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in the Number of Weekly Cluster Headache Attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Comfort B Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adverse Device Effect
Endpoint domain: Adverse events/effects
Primary endpoint: Corneal fluorescein staining score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial fullness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacy costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of overall recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of overall retention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intervention usability as assessed by the Usability score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intervention acceptability as assessed by the acceptability score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in cardiac output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in systemic vascular resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: success of insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in average time-window for energy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weekly adherence rates for time restricted eating (TRE)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: change of arterial oxygen partial pressure (PaO2)/fraction of inspired oxygen (FiO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Device related Composite Endpoint (Target Lesion Failure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes